Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00356057 · ClinicalTrials.gov registry record · NA
Investigational Device Exemption (IDE) Study for the Approval of Closed Loop Stimulation (CLS) and Cardiac Resyncronization Pacing Therapies (CRT) for the Treatment of Atrial Fibrillation (AF) With Ablate and Pace
A NA study, sponsored by Biotronik.
- Terminated
- Registry status
- NA
- Development phase
- 153
- Enrollment target
NCT00356057 is a NA study that was terminated before completion, run by Biotronik. The registered enrollment target is 153 participants.
The verdict
NCT00356057, a NA study, was terminated before completion, sponsored by Biotronik.
- TERMINATED
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the safety and effectiveness of biventricular pacing over conventional right ventricular pacing in patients with persistent or permanent, symptomatic atrial fibrillation undergoing atrioventricular (AV) node ablation and permanent pacing therapy.
Interventions
- DEVICE Protos DR/CLS and Stratos LV CRT pacemakers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2004-12 |
| Est. Completion | 2008-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00356057
The ClinicalTrials.gov registry entry for NCT00356057 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biotronik, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Protos DR/CLS and Stratos LV CRT pacemakers is the first listed.
NCT00356057 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00356057 about?
NCT00356057 is a clinical study titled "Investigational Device Exemption (IDE) Study for the Approval of Closed Loop Stimulation (CLS) and Cardiac Resyncronization Pacing Therapies (CRT) for the Treatment of Atrial Fibrillation (AF) With Ablate and Pace". The purpose of this study is to demonstrate the safety and effectiveness of biventricular pacing over conventional right ventricular pacing in patients with persistent or permanent, symptomatic atrial fibrillation undergoing atrioventricular (AV) node ablation and permanent pacing therapy.
What is the current status of trial NCT00356057?
This trial is currently terminated. It is a NA study. The enrollment target is 153 participants. The study started on 2004-12. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00356057?
The interventions under investigation include: Protos DR/CLS and Stratos LV CRT pacemakers (DEVICE).
Who is sponsoring clinical trial NCT00356057?
This trial is sponsored by Biotronik, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.